A major new report from the European Association for the Study of the Liver (EASL) and The Lancet Commission is urging European governments to adopt stricter alcohol policies, including mandatory health warning labels, tighter restrictions on digital alcohol marketing targeting young people, and a reassessment of alcohol taxation across the continent.
The report, published by the EASL-Lancet Commission on Liver Health in Europe, warns that liver disease has become one of the region’s most pressing public health challenges and should be integrated into broader strategies addressing non-communicable diseases.
Liver Disease Deaths Continue to Rise
According to the commission, approximately 780 people die every day in Europe from cirrhosis or liver cancer, conditions that are considered largely preventable. Combined, these diseases account for around 284,000 deaths annually across Europe.
The report highlights a particularly alarming increase in liver cancer mortality. Since 2000, liver cancer deaths in Europe have risen by more than 50%, climbing from approximately 43,000 deaths to nearly 69,000 in 2023.
Experts behind the study identify alcohol consumption, obesity, and viral hepatitis as the primary drivers of liver disease across the region. In addition, the report points to the growing prevalence of fatty liver disease linked to metabolic dysfunction, often associated with unhealthy diets, excess body weight, and alcohol use.
The commission argues that these health risks are strongly influenced by factors such as pricing, advertising, and the widespread availability of alcoholic beverages and ultra-processed foods.
Alcohol Industry Faces Potential Regulatory Changes
The recommendations could have significant implications for Europe’s wine, beer, and spirits industries.
Among the proposed measures are visible health warning labels on alcoholic beverages, stricter limitations on digital advertising, and tighter controls on promotional activities targeting minors and young adults.
The commission also recommends reviewing alcohol taxation policies as part of broader public health strategies designed to reduce harmful consumption patterns.
Digital marketing has emerged as a particular concern, with health experts warning that younger consumers are increasingly exposed to alcohol promotion through social media platforms and influencer campaigns.
The report suggests that stronger regulation in these areas could play a meaningful role in reducing long-term liver disease rates.
Economic Impact Estimated at €55 Billion Annually
Beyond healthcare concerns, the report stresses the broader economic consequences of liver disease in Europe.
According to the commission, the economies of the European Union and associated European countries would collectively be approximately €55 billion larger each year without the burden of liver disease.
Researchers estimate that liver-related illnesses reduce regional GDP by around 0.3% annually through lost productivity, premature deaths, healthcare costs, and work absences.
The findings reinforce growing calls among health organizations for governments to view liver disease not only as a medical issue but also as a major economic challenge.
WHO Calls for Immediate Government Action
Hans Kluge, regional director for Europe at the World Health Organization, described the findings as a warning signal for policymakers across the continent.
He emphasized that cirrhosis and liver cancer together account for nearly 780 deaths every day within the WHO European Region and stressed that governments must address the underlying causes driving these diseases.
According to Kluge, tackling alcohol consumption, unhealthy diets, obesity, and viral hepatitis must become part of a comprehensive strategy against non-communicable diseases.
The commission also warns that many patients are diagnosed too late, often when treatment options are limited and outcomes significantly worsen.
Focus on Early Detection and Healthcare Access
The report outlines several recommendations designed to improve prevention, diagnosis, and treatment across Europe.
These include expanding testing and treatment programs for viral hepatitis among migrants and underserved populations, strengthening integrated healthcare systems connecting primary care and specialists, and improving access to affordable medicines through joint procurement initiatives between EU member states.
The commission also recommends incorporating liver health indicators into existing European health monitoring systems to improve early detection and long-term disease tracking.
Marko Korenjak called for a transition “from words to action,” emphasizing the importance of early screening, coordinated care, and stronger preventive measures addressing the root causes of liver disease.
“The Evidence Already Exists”
The report concludes that nearly half of the liver disease burden in Europe could be reduced through policies targeting behavioral risk factors.
Measures such as alcohol taxation, restrictions on harmful marketing, wider health screening, and improved treatment access are expected not only to improve public health outcomes but also to generate economic benefits for healthcare systems and public finances.
Debbie Shawcross stated that Europe already possesses the scientific knowledge and healthcare tools needed to reverse current trends.
“What is lacking is not evidence, but action,” she said.
The commission is now calling on the European Union, national governments, and the WHO to place liver health at the center of future healthcare planning and to strengthen regulation of commercial activities linked to alcohol and other harmful consumer products.
Source: Vinetur